Leadership: Page 10
-
Podcast
Woman of the Week: Exelixis’ Dr. Vicki Goodman
With several blockbuster products under her belt, veteran oncologist and drug developer Dr. Vicki Goodman is looking to further evolve Exelixis’ pipeline to address hard-to-treat cancers.
By Taren Grom • Dec. 14, 2022 -
At the heart of hematology breakthroughs, a community of researchers and patients comes together
As new and advanced therapies are revealed at the annual meeting of the American Society of Hematology this week, the patients are always at the center.
By Michael Gibney • Dec. 13, 2022 -
Trendline
Clinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
Tracker
The 2023 PharmaVoice Year in Preview
Here’s a look at how industry leaders are navigating the key issues of 2023.
Dec. 12, 2022 -
The pharma giants making the biggest strides with global drug access
A recent report ranks the top 20 pharma companies by how well they’re boosting a critical component of health equity.
By Kelly Bilodeau • Dec. 12, 2022 -
With FDA filing on the horizon, Karuna appoints new CEO
Allergan alum Bill Meury will take the helm as current CEO Steve Paul transitions to lead R&D.
By Karissa Waddick • Dec. 9, 2022 -
Q&A
For Duchenne-focused Sarepta, gene therapy is the natural next step
The company with three marketed RNA drugs for Duchenne muscular dystrophy is taking the logical leap into gene therapies with a candidate under review at the FDA.
By Michael Gibney • Dec. 8, 2022 -
Q&A
Takeda’s global quest for health equity
Takeda’s Center for Health Equity and Patient Affairs is built to address health inequality around the world and aims to raise the bar for the pharma industry.
By Taren Grom • Dec. 8, 2022 -
10 noteworthy pharma leadership shake-ups this year
From GSK to Roche to Biogen, these were the most impactful executive changes at leading pharma companies in 2022.
By Karissa Waddick • Dec. 7, 2022 -
Podcast
Woman of the Week: Simcha Therapeutics’ Beatrice McQueen
From sea sponges to cytokines, the chief operating officer’s career has come full circle as she pursues a new approach to treating cancer via the immune system.
By Taren Grom • Dec. 7, 2022 -
Opinion
Healthcare tech’s biggest busts
The metaverse, blockchain, DCTs and more — here are some of the most recent fails in healthcare tech.
By Taren Grom • Dec. 2, 2022 -
10 of our most popular articles in 2022
Methadone, rock ‘n’ roll, clinical trial overhauls — here’s a look at our most-read stories of the year.
By Meagan Parrish • Nov. 30, 2022 -
Podcast
Woman of the Week: Surface Oncology’s Dr. Alison O’Neill
With more than two decades of experience in oncology R&D, Dr. Alison O’Neill is helping Surface unlock the potential of next-gen immunotherapies by targeting the tumor microenvironment.
By Taren Grom • Nov. 30, 2022 -
One biotech’s approach to science-driven innovation
Why some in the industry say fostering creativity in drug development is all about work structures.
By Karissa Waddick • Nov. 29, 2022 -
5 enduring mysteries of the Barry and Honey Sherman murders
After nearly five years, the homicide case involving pharma billionaires continues to perplex investigators.
By Meagan Parrish • Nov. 28, 2022 -
Podcast
Woman of the Week: Myriad Genetics’ Nicole Lambert
Empowered by her own cancer journey, Nicole Lambert is using her platform as chief operating officer of the genetic testing powerhouse to change the trajectory of care for millions of women.
By Taren Grom • Nov. 23, 2022 -
Executive changes at Teva, Eversana could spell commercial growth in the new year
With their latest personnel moves, these life sciences companies are preparing for major business shifts.
By Karissa Waddick • Nov. 23, 2022 -
Opinion
Hybrid work is here to stay — here’s how leaders should adjust
Executives across the life sciences share their tips for navigating the new norm of remote work.
By Taren Grom • Nov. 18, 2022 -
Q&A
The legacy of Glen de Vries: Our last interview with the pioneering entrepreneur
Recorded just weeks before his passing, our sit-down interview with the legendary medical sciences entrepreneur showcased his passion for pushing the industry toward its next frontier.
By Taren Grom • Nov. 11, 2022 -
Podcast
Woman of the Week: 82VS’s Trier Bryant
Welcome to the Woman of the Week podcast, a weekly discussion that illuminates the unique stories of women leaders who are catalyzing change throughout the life sciences industry. You can check out all our podcast episodes here. Not every leader makes it their mission to go where the fire ...
By Taren Grom • Nov. 9, 2022 -
Podcast
Woman of the Week: City of Hope’s Gulden Mesara
Charged with bridging the 100-year-old research center to its future mission of holistic patient cancer care, Mesara is bringing decades of experience in communications and culture creation.
By Taren Grom • Nov. 2, 2022 -
Vaccine chief’s exit spurs new slate of GSK executive changes
How the pharma giant is consolidating power as it looks to become a dominant force in the vaccine market.
By Karissa Waddick • Oct. 31, 2022 -
Opinion
Pharma execs on creating a better workplace culture
Top women execs speak to the leadership skills they are embracing as the industry adjusts to a new normal.
By Taren Grom • Oct. 28, 2022 -
Opinion
What’s keeping pharma leaders up at night
C-suite execs in the life sciences share their late-night thoughts including innovation, patient access and market factors.
By Taren Grom • Oct. 21, 2022 -
J&J reveals just how much economic turbulence is affecting Big Pharma
The healthcare giant showed pharmaceutical gains, but that's no thanks to the economic environment of persistent inflation and a strong U.S. dollar.
By Michael Gibney • Oct. 20, 2022 -
Podcast
Woman of the Week: Exscientia’s Charlotte Deane
Is the industry ready for a biologic discovery revolution? Charlotte Deane, chief scientist of biologics AI at Exscientia, thinks so.
By Taren Grom • Oct. 19, 2022